Industry news

Russian Minister of Health: real medical empire created for guests of Olympic Sochi

ITAR-TASS

An “entire medical empire” has been created for residents and guests of Russia’s Black Sea resort Sochi, which is hosting the 22nd Olympic Winter Games, Russian Minister of Health Veronika Skvortsova said in an interview published in Thursday’s issue of the Rossiiskaya Gazeta daily.

US biotech stocks soar to new record high

Arash Massoudi and Michael Mackenzie / Financial Times

Investors are buying further into booming US biotechnology stocks, with the sector soaring to a new record after delivering double-digit returns in 2014.

Illumina and Yuri Milner will back a genomics startup incubator in San Francisco

Galen Moore / FierceMedicalDevices

Illumina ($ILMN) is throwing its cachet and its $1,000 genome sequencing system behind a San Francisco genomics startup incubator backed by Russian billionaire Yuri Milner.

The Russian venture capital industry has grown tenfold since 2007

EY / press-release

EY, the leading services provider for strategic growth markets, and RVC, the key Russian institute for venture industry development, announce Russian and global venture markets in 2007–2013 survey. The study presents an in-depth view of the market, features new statistical data, and contains insights from the venture industry leaders.

U.S. rep rips the FDA's efforts to speed up drug approvals

Damian Garde, FierceBiotech

Over the past few years, the FDA has unveiled a spate of new approval pathways in hopes of getting much-needed treatments on the market faster. But in the rush to accelerate drug development, the agency has wound up putting patients at risk, according to one congresswoman, fast-tracking unproven therapies despite serious safety concerns.

BRICS Medical Device Market Reports

ReportLinker

With a combined population of 3 0 billion people and with significant unmet medical need, the challenges and opportunities of the BRIC markets are considerable The economic downturn has affected these markets varyingly; for example, the Brazilian import market may be affected by disadvantageous US$ exchange rates, but China is affected more by a weak economy in the USA, its major market Significant growth rates are impressive, but the low starting point – along with a range of other operational issues – means companies must be targeted in the opportunities they pursue.

Reports Of U.S. Biomedical R&D Demise – A Great Exaggeration

Rob Wright, Life Science Leader

Prior to heading out to the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco last month, I stumbled across several article headlines indicating the United States’ domination of global biomedical R&D was fading. What metric was used to determine this? R&D spend. According to “new” research from the University of Michigan Health System, the U.S. share of the global biomedical R&D business declined from 51 percent to a mere 45 percent from 2007 to 2012. 

How To Launch A Biotech Start-Up

Suzanne Elvidge, Life Science Leader

Whether in the early days of DNA cloning in the 1970s, or the boom of the 1980s and 1990s, biotechnology and biotech start-ups have represented the cutting edge of the biopharma and healthcare industry. For those fascinated by the idea of entering the hurly-burly start-up world, Index Ventures hosted “Playground” in October 2013, covering the entire process, from thinking up the idea for a new company to planning for the exit.

Russian physicians visit ARMC, learn about healthcare and hospital systems in US

April Burkhart, Online Athens

Delegates of Russia’s health care community toured Athens Regional Medical Center on Tuesday as part of trip sponsored by Rotary International and the Athens Rotary Club to learn more about health care practices in the United States and technology used in American hospitals.

Collaborations between foreign and domestic pharma companies in Russia mark the start of a trend

Kavita Rainova, IHS Global Insight Daily Analysis

Over the past few months, there has been a steady inflow of news about collaboration between foreign pharma companies and Russian firms, along with news about foreign companies basing production processes in Russia.